Alipi V. Naydenov - Publications

Affiliations: 
Neurobiology and Behavior University of Washington, Seattle, Seattle, WA 
Area:
endocannabinoids, huntington's disease, striatal signaling

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Davis MI, Crittenden JR, Feng AY, Kupferschmidt DA, Naydenov A, Stella N, Graybiel AM, Lovinger DM. The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra. Plos One. 13: e0191436. PMID 29466446 DOI: 10.1371/Journal.Pone.0191436  0.586
2017 Amos PJ, Fung S, Case A, Kifelew J, Osnis L, Smith CL, Green K, Naydenov A, Aloi M, Hubbard JJ, Ramakrishnan A, Garden GA, Jayadev S. Modulation of Hematopoietic Lineage Specification Impacts TREM2 Expression in Microglia-Like Cells Derived From Human Stem Cells. Asn Neuro. 9: 1759091417716610. PMID 28683563 DOI: 10.1177/1759091417716610  0.59
2016 Cherry AE, Haas BR, Naydenov AV, Fung S, Xu C, Swinney K, Wagenbach M, Freeling J, Canton DA, Coy J, Horne EA, Rickman B, Vicente JJ, Scott JD, Ho RJ, et al. ST-11: a new brain-penetrant microtubule-destabilizing agent with therapeutic potential for glioblastoma multiforme. Molecular Cancer Therapeutics. PMID 27325686 DOI: 10.1158/1535-7163.Mct-15-0800  0.521
2015 Cherry A, Haas B, Naydenov A, Fung S, Xu C, Swinney K, Wagenbach M, Freeling J, Canton D, Coy J, Horne E, Rickman B, Scott J, Ho R, Liggitt D, et al. ATPS-06BRAIN-PENETRANT ALKYLINDOLE COMPOUNDS PROMOTE APOPTOSIS IN GLIOMA CELLS THROUGH MICROTUBULE DESTABILIZATION Neuro-Oncology. 17: v19.2-v19. DOI: 10.1093/Neuonc/Nov204.06  0.541
2014 Naydenov AV, Sepers MD, Swinney K, Raymond LA, Palmiter RD, Stella N. Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice. Neurobiology of Disease. 71: 140-50. PMID 25134728 DOI: 10.1016/J.Nbd.2014.08.009  0.573
2014 Naydenov AV, Horne EA, Cheah CS, Swinney K, Hsu KL, Cao JK, Marrs WR, Blankman JL, Tu S, Cherry AE, Fung S, Wen A, Li W, Saporito MS, Selley DE, et al. ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice. Neuron. 83: 361-71. PMID 25033180 DOI: 10.1016/J.Neuron.2014.06.030  0.672
2014 Kow RL, Jiang K, Naydenov AV, Le JH, Stella N, Nathanson NM. Modulation of pilocarpine-induced seizures by cannabinoid receptor 1. Plos One. 9: e95922. PMID 24752144 DOI: 10.1371/Journal.Pone.0095922  0.565
2013 Chen DH, Naydenov A, Blankman JL, Mefford HC, Davis M, Sul Y, Barloon AS, Bonkowski E, Wolff J, Matsushita M, Smith C, Cravatt BF, Mackie K, Raskind WH, Stella N, et al. Two novel mutations in ABHD12: expansion of the mutation spectrum in PHARC and assessment of their functional effects. Human Mutation. 34: 1672-8. PMID 24027063 DOI: 10.1002/Humu.22437  0.531
2013 Horne EA, Coy J, Swinney K, Fung S, Cherry AE, Marrs WR, Naydenov AV, Lin YH, Sun X, Keene CD, Grouzmann E, Muchowski P, Bates GP, Mackie K, Stella N. Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models. The European Journal of Neuroscience. 37: 429-40. PMID 23167744 DOI: 10.1111/Ejn.12045  0.686
2012 Chen D, Davis M, Mefford H, Sul Y, Naydenov A, Barloon AS, Wolff J, Matsushita M, Smith C, Stella N, Raskind W, Bird T. Two Novel Mutations in ABHD12 Expand the Mutation Spectrum in PHARC (P05.141) Neurology. 78: P05.141-P05.141. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P05.141  0.536
2011 Sillivan SE, Black YD, Naydenov AV, Vassoler FR, Hanlin RP, Konradi C. Binge cocaine administration in adolescent rats affects amygdalar gene expression patterns and alters anxiety-related behavior in adulthood. Biological Psychiatry. 70: 583-92. PMID 21571252 DOI: 10.1016/J.Biopsych.2011.03.035  0.581
2010 Naydenov AV, Vassoler F, Luksik AS, Kaczmarska J, Konradi C. Mitochondrial abnormalities in the putamen in Parkinson's disease dyskinesia. Acta Neuropathologica. 120: 623-31. PMID 20740286 DOI: 10.1007/S00401-010-0740-8  0.596
2009 Gregg JR, Herring NR, Naydenov AV, Hanlin RP, Konradi C. Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats. Schizophrenia Research. 113: 277-87. PMID 19570651 DOI: 10.1016/J.Schres.2009.05.023  0.618
2007 Naydenov AV, MacDonald ML, Ongur D, Konradi C. Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Archives of General Psychiatry. 64: 555-64. PMID 17485607 DOI: 10.1001/Archpsyc.64.5.555  0.589
2006 Todtenkopf MS, Parsegian A, Naydenov A, Neve RL, Konradi C, Carlezon WA. Brain reward regulated by AMPA receptor subunits in nucleus accumbens shell. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 11665-9. PMID 17093088 DOI: 10.1523/Jneurosci.3070-06.2006  0.621
2006 Black YD, Maclaren FR, Naydenov AV, Carlezon WA, Baxter MG, Konradi C. Altered attention and prefrontal cortex gene expression in rats after binge-like exposure to cocaine during adolescence. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9656-65. PMID 16988036 DOI: 10.1523/Jneurosci.2391-06.2006  0.591
2006 Youngs RM, Chu MS, Meloni EG, Naydenov A, Carlezon WA, Konradi C. Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 6031-9. PMID 16738246 DOI: 10.1523/Jneurosci.0580-06.2006  0.605
2006 MacDonald ML, Naydenov A, Chu M, Matzilevich D, Konradi C. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disorders. 8: 255-64. PMID 16696827 DOI: 10.1111/J.1399-5618.2006.00302.X  0.611
Show low-probability matches.